Removing binding sites for an oncogene can slow cancer cell growth, researchers say
Cancer cell growth could be slowed down by removing binding sites for an oncogene, researchers…
September 29, 2022 - 3 minutes
CRISPR: A Promising Industry With Many Questions Unanswered
The gene-editing tool CRISPR-Cas9 has taken over the life sciences world since its development in 2012. CRISPR has changed the way biology research is done, simplifying and speeding up the study of diseases and the discovery of drugs, as well as having a huge impact on crop and food development. Among all its possible applications, the fact that CRISPR can be used to tweak the human genome has made it especially promising for previously difficult-to-treat diseases.
But how does CRISPR work? What kind of therapies are being developed? How is the genome-editing market evolving? And how are stakeholders navigating the complex intellectual property around this technology? Find out the answers to these questions and more on this page.
Show More
The Genome Editing Toolbox: ZFNS, TALENS, and CRISPR in Biomedicine
This report covers the industry’s most common genome-editing tools, like CRISPR-Cas9, provides exclusive insights by experts, looks at the market, and addresses future applications and challenges of genome-editing tools.
Go to ReportLatest CRISPR Articles
Scribe Therapeutics enters into agreement with Sanofi for use of its CRISPR technologies
Scribe Therapeutics has entered into an agreement with Sanofi which will allow Sanofi use of…
September 28, 2022 - 2 minutes
Scope Biosciences and WUR to improve CRISPR-Cas technology with new funds
Wageningen University & Research (WUR), and its spinoff Scope Biosciences, have received a grant of…
September 13, 2022 - 3 minutes
CRISPR/CAS9 strategic alliance between Sigma-Aldrich and genOway expanded
Sigma-Aldrich Co LLC, along with genOway, a preclinical research model space company, announced today (September…
September 8, 2022 - 3 minutes
Beyond Biotech podcast 11: Ilya Pharma, IRB Barcelona, Krystal Biotech, Phase Genomics
This week it’s another four interview podcast, and the introduction of a new feature. Our…
August 26, 2022 - 4 minutes
Gene therapies for lung cancer identified by international team of scientists
Gene therapies for lung cancer can be found by CRISPR genome editing technology, an international…
August 24, 2022 - 2 minutes
Study says gene editing with CRISPR/Cas9 can lead to cell toxicity and genome instability
CRISPR/Cas9 is a commonly used gene editing technique. CRISPR allows the introduction of a desired…
August 9, 2022 - 3 minutes
Deciphering the molecular mechanisms of severe COVID-19
Researchers from Fujita Health University School of Medicine in Japan have been investigating COVID-19 to…
August 3, 2022 - 4 minutes
SNIPR Biome announces new patent granted for applications targeting E. coli infections
SNIPR Biome has today (August 2) announced that it has been granted a patent for…
August 2, 2022 - 2 minutes
CRISPR Can Help The Switch To Sustainable Cosmetics
The cosmetics industry is looking for greener ingredients as consumers demand more sustainable products. According…
May 16, 2022 - 5 minutes
UK Startup Lands €5M Seed Round to Produce Gene-Edited Crops with AI
Phytoform, a London- and Boston-based startup, has received a €5M ($5.7M) investment to develop gene-edited…
December 17, 2021 - 4 minutes
CRISPR-Cas9: The Gene Editing Tool Changing the World
CRISPR-Cas9 has taken the world by storm with the promise of making gene editing much…
November 3, 2021 - 11 minutes
